10:30
2026-08-29
mercurynews.com
artificial-intelligence
Jarvis: A cancer vaccine is closer than ever
Merck & Co. and Moderna Inc. reported that their personalized mRNA cancer vaccine intismeran, combined with the immunotherapy Keytruda, kept melanoma from returning in a large late-stage Phase 3 trial…